New appointment at NDA
This article was originally published in Scrip
Executive Summary
Keith Wibley is to join the European regulatory affairs consulting group NDA as director of pharmacovigilance. He joins from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA), where he has spent the last three years as a pharmacovigilance inspector.